Acute myeloid leukemia targets for bispecific antibodies

por Hoseini, S S, Cheung, N K
Publicado 2017

Acute myeloid leukemia targets for bispecific antibodies

por Hoseini, S S, Cheung, N K
Publicado 2017

Large Traumatic Pneumatocele in a 2-Year-Old Child

por Cheung, N. K., James, A., Kumar, R.
Publicado 2013

Genetic heterogeneity and clonal evolution in neuroblastoma

por Mora, J, Cheung, N-K V, Gerald, W L
Publicado 2001

Seatbelt: A Double-Edged Sword

por Raychaudhuri, P., Cheung, N. K., Bendinelli, C., Puvaneswary, M., Ferch, R., Kumar, Rajendra
Publicado 2012

Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2.

por Patel, K., Rossell, R. J., Pemberton, L. F., Cheung, N. K., Walsh, F. S., Moore, S. E., Sugimoto, T., Kemshead, J. T.
Publicado 1989

Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21–23 in the biology of favourable stage 4 tumours

por Mora, J, Alaminos, M, de Torres, C, Illei, P, Qin, J, Cheung, N-K V, Gerald, W L
Publicado 2004

Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma

por Villasante, A., Sakaguchi, K., Kim, J., Cheung, N.K., Nakayama, M., Parsa, H., Okano, T., Shimizu, T., Vunjak-Novakovic, G.
Publicado 2017

ALK inhibitor resistance in ALK(F1174L)-driven neuroblastoma is associated with AXL activation and induction of EMT

por Debruyne, D N, Bhatnagar, N, Sharma, B, Luther, W, Moore, N F, Cheung, N-K, Gray, N S, George, R E
Publicado 2016

Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential

por Zhao, Q, Ahmed, M, Tassev, D V, Hasan, A, Kuo, T-Y, Guo, H-F, O'Reilly, R J, Cheung, N-K V
Publicado 2015